About Bela Kis
- Accolades
-
-
Pleural and Lung Cancer
-
Works for Specialty Center
-
Board certified in Diagnostic Radiology and Interventional Radiology
-
He is currently the lead investigator in a groundbreaking phase II transarterial chemoperfusion clinical trial for patients with unresectable pleural mesothelioma.
It involves identifying specific blood vessels that feed the tumors, then overloading those vessels with high doses of specific chemotherapy agents to stop the cancer growth without exposing the rest of the body.
He is heavily involved with image guided tumor therapy, image-guided biopsies and urinary and biliary interventions, arterial and venous stenting. He also does minimally invasive percutaneous tumor ablation.
Kis came to Moffitt after completing a radiology residency and interventional radiology fellowship at Brigham and Women’s Hospital, Harvard Medical School in Boston.
He holds a doctorate in cerebral microcirculation from University of Szeged in Hungary and did a post-doctoral fellowship and surgery internship at Wake Forest University Baptist Medical Center in Winston-Salem, North Carolina.
See More Top Mesothelioma DoctorsDisclaimer: Dr. Bela Kis has no professional affiliation with Asbestos.com.
Get the Best Treatment Options
Find a Doctor
Find a Mesothelioma Clinical Trial Near You
Get Help NowShare this article
Last Modified October 17, 2018
Tim Povtak
Senior Content Writer
Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.
2 Cited Article Sources
-
Moffitt Cancer Center. (n.d.). Bela Kis, MD, PhD.
Retrieved from: https://moffitt.org/providers/bela-kis/ - U.S. News & World Report. (n.d.). Dr. Bela Kis. Retrieved from: https://health.usnews.com/doctors/bela-kis-714554
